MG-63細(xì)胞 
	
		細(xì)胞形態(tài):	成纖維樣
	
	
		年限:	14 years
	
	
		生長狀態(tài):	貼壁生長
	
	
		數(shù)量:	大量
	
	
		器官來源:	骨
	
	
		ATCC Number:	CRL-1427?
	
	
		相關(guān)**:	骨肉瘤
	
	
		是否是腫瘤細(xì)胞:	1
	
	
		物種來源:	人
	
	
		運(yùn)輸方式:	凍存運(yùn)輸
	
	
		Designations:	MG-63
	
	
		Depositors:	 A Billiau
	
	
		MG-63細(xì)胞Biosafety Level:	1
	
	
		Shipped:	frozen
	
	
		Medium & Serum:	See Propagation
	
	
		Growth Properties:	adherent
	
	
		Organism:	Homo sapiens
	
	
		Morphology:	fibroblast
	
	
		
	
	
		Source:	Organ: bone
	
	
		Disease: osteosarcoma
	
	
		Cellular Products:	interferon
	
	
		Permits/Forms:	In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
	
	
		Applications:	transfection host
	
	
		Receptors:	transforming growth factor beta (TGF-beta) RI, expressed
	
	
		transforming growth factor beta (TGF-beta) RII, expressed
	
	
		DNA Profile (STR): MG-63細(xì)胞Amelogenin: X,Y
	
	
		CSF1PO: 10,12
	
	
		D13S317: 11
	
	
		D16S539: 11
	
	
		D5S818: 11,12
	
	
		D7S820: 10
	
	
		THO1: 9.3
	
	
		TPOX: 8,11
	
	
		vWA: 16,19
	
	
		Cytogenetic Analysis:	This is a hypotriploid human cell line. The modal chromosome number was 66 occurring in 44% of cells. The rate of cells with higher ploidies was 2.0%. Eighteen to 19 marker chromosomes were common to all cells.
	
	
		Age:	14 years
	
	
		Gender:	male
	
	
		Ethnicity:	Caucasian
	
	
		Comments:	High levels of interferon production can be induced using polyinosinic - polycytidylic acid, cycloheximide and actinomycin D.
	
	
		Propagation: MG-63細(xì)胞ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Eagle's Minimum Essential Medium, Catalog No. 30-2003. To make the complete growth medium, add the following components to the base medium: heat-inactivated fetal bovine serum to a final concentration of 10%.
	
	
		Atmosphere: air, 95%; carbon dioxide (CO2), 5%
	
	
		Temperature: 37.0°C
	
	
		Subculturing:	Protocol:
	
	
		Remove and discard culture medium.
	
	
		Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor.
	
	
		Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
	
	
		Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37?C to facilitate dispersal.
	
	
		Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
	
	
		Add appropriate aliquots of the cell suspension to new culture vessels.
	
	
		Incubate cultures at 37?C.
	
	
		
	
	
		Subcultivation Ratio: A subcultivation ratio of 1:4 to 1:8 is recommended
	
	
		Medium Renewal: 2 to 3 times per week
	
	
		Preservation:	Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO
	
	
		Storage temperature: liquid nitrogen vapor phase
	
	
		Related Products:	Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2003
	
	
		References:	1058: Billiau A, et al. MG-63細(xì)胞Human interferon: mass production in a newly established cell line, MG-63. Antimicrob. Agents Chemother. 12: 11-15, 1977. PubMed: 883813
	
	
		23014: Takeuchi Y, et al. Relationship between actions of transforming growth factor (TGF)-beta and cell surface expression of its receptors in clonal osteoblastic cells. J. Cell. Physiol. 162: 315-321, 1995. PubMed: 7860639
	
	
		32445: Yee A, et al. Biochemical characterization of the human cyclin-dependent protein kinase activating kinase. J. Biol. Chem. 271: 471-477, 1996. PubMed: 8550604